BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33483333)

  • 1. Regulatory T Cell-Derived TRAIL Is Not Required for Peripheral Tolerance.
    Dadey RE; Grebinoski S; Zhang Q; Brunazzi EA; Burton A; Workman CJ; Vignali DAA
    Immunohorizons; 2021 Jan; 5(1):48-58. PubMed ID: 33483333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
    Ikeda T; Hirata S; Fukushima S; Matsunaga Y; Ito T; Uchino M; Nishimura Y; Senju S
    J Immunol; 2010 Nov; 185(9):5259-67. PubMed ID: 20921531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
    Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN
    Front Immunol; 2018; 9():15. PubMed ID: 29403497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice.
    Cretney E; McQualter JL; Kayagaki N; Yagita H; Bernard CC; Grewal IS; Ashkenazi A; Smyth MJ
    Immunol Cell Biol; 2005 Oct; 83(5):511-9. PubMed ID: 16174101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
    Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S
    J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
    Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
    J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4
    Moorman CD; Bastian AG; DeOca KB; Mannie MD
    J Neuroinflammation; 2020 Jun; 17(1):180. PubMed ID: 32522287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.
    Hilliard B; Wilmen A; Seidel C; Liu TS; Göke R; Chen Y
    J Immunol; 2001 Jan; 166(2):1314-9. PubMed ID: 11145715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
    Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
    J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.
    Huarte E; Jun S; Rynda-Apple A; Golden S; Jackiw L; Hoffman C; Maddaloni M; Pascual DW
    J Immunol; 2016 Jun; 196(12):5036-46. PubMed ID: 27194787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective deletion of Eos (Ikzf4) in T-regulatory cells leads to loss of suppressive function and development of systemic autoimmunity.
    Gokhale AS; Gangaplara A; Lopez-Occasio M; Thornton AM; Shevach EM
    J Autoimmun; 2019 Dec; 105():102300. PubMed ID: 31296356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4(+)CD25 (+) Treg apoptosis.
    Diao Z; Shi J; Zhu J; Yuan H; Ru Q; Liu S; Liu Y; Zheng D
    Cancer Immunol Immunother; 2013 Apr; 62(4):653-63. PubMed ID: 23143747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.
    Matsushita T; Horikawa M; Iwata Y; Tedder TF
    J Immunol; 2010 Aug; 185(4):2240-52. PubMed ID: 20624940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in T regulatory cells between mouse strains frequently used in immunological research: Treg cell quantities and subpopulations in NOD, B6 and BALB/c mice.
    Godoy GJ; Paira DA; Olivera C; Breser ML; Sanchez LR; Motrich RD; Rivero VE
    Immunol Lett; 2020 Jul; 223():17-25. PubMed ID: 32330480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
    Dorothée G; Vergnon I; Menez J; Echchakir H; Grunenwald D; Kubin M; Chouaib S; Mami-Chouaib F
    J Immunol; 2002 Jul; 169(2):809-17. PubMed ID: 12097384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPR54 deficiency reduces the Treg population and aggravates experimental autoimmune encephalomyelitis in mice.
    Xing R; Liu F; Yang Y; Cui X; Wang T; Xie L; Zhao Y; Fang L; Yi T; Zheng B; Liu M; Chen H
    Sci China Life Sci; 2018 Jun; 61(6):675-687. PubMed ID: 29931449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
    Ghosh D; Curtis AD; Wilkinson DS; Mannie MD
    J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory and T Effector Cells Have Overlapping Low to High Ranges in TCR Affinities for Self during Demyelinating Disease.
    Hood JD; Zarnitsyna VI; Zhu C; Evavold BD
    J Immunol; 2015 Nov; 195(9):4162-70. PubMed ID: 26385521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis.
    Gocke AR; Lebson LA; Grishkan IV; Hu L; Nguyen HM; Whartenby KA; Chandy KG; Calabresi PA
    J Immunol; 2012 Jun; 188(12):5877-86. PubMed ID: 22581856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.